Chlorpromazine hydrochloride
SIAL/C1900000 - European Pharmacopoeia (EP) Reference Standard
Synonym: 2-
CAS Number: 69-09-0
Empirical Formula (Hill Notation): C17H19ClN2S · HCl
Molecular Weight: 355.33
MDL Number: MFCD00012654
Linear Formula: C17H19ClN2S · HCl
Product Type: Chemical
API family | chlorpromazine |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C17H19ClN2S.ClH/c1-19( |
InChI key | FBSMERQALIEGJT-UHFFFAOYSA |
manufacturer/tradename | EDQM |
SMILES string | Cl[H].CN(C)CCCN1c2ccccc2S |
Application: | Substitute for benzidine, o-dianisidine, and o-tolidine in the determination of microquantities of hemoglobin and peroxidase. |
Biochem/physiol Actions: | Chlorpromazine demonstrates cytotoxic and antiproliferative activity against leukemic cells, but does not affect the viability of normal lymphocytes. |
Biochem/physiol Actions: | Phenothiazine antipsychotic; D2 dopamine receptor antagonist, H1 histamine receptor antagonist; inhibits calmodulin-dependent stimulation of cyclic nucleotide phosphodiesterase and nitric oxide synthase. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Packaging: | The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
Symbol | GHS06 |
Signal word | Danger |
Hazard statements | H301 - H330 |
Precautionary statements | P260 - P264 - P270 - P271 - P284 - P304 + P340 + P310 |
RIDADR | UN 2811PIH 6.1 / PGI |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
UNSPSC | 41116107 |